HONG TANG, MD, FACP

HONG TANG, MD, FACP, currently serves as President and Chief Medical Officer at OnQuality Pharmaceuticals Ltd., where contributions include co-founding the company and holding the role of Interim CEO. Prior experiences encompass leadership positions in medical affairs at Dendreon and Juno Therapeutics, as well as an Executive Medical Director role at Astellas Pharma. Additional tenure at Bristol-Myers Squibb included directorships in Oncology and Virology Medical Affairs, and earlier experience involved clinical research at Human Genome Sciences and serving as a Medical Officer at the National Institutes of Health.